Utama › Nefrosis Lipoid › Michigan
Kajian klinikal Nefrosis Lipoid di Michigan
5 kajian untuk Nefrosis Lipoid sedang mencari peserta di lokasi di Michigan.
Bandar di Michigan
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- University of Michigan Health System - Ann Arbor- Site Number : 8400010, Ann Arbor
Mengambil pesertaFasa 2
Umur 16 hingga 75 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06500702Nephrotic Syndrome Study Network
- CS Mott Children's Hospital, University of Michigan, Ann Arbor
- University of Michigan Medical Center, Ann Arbor
Mengambil pesertaKajian pemerhatian
Sehingga umur 80 · Semua jantina · Dikemas kini 10 Jun 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- C.S. Mott Children's Hospital, Ann Arbor
Mengambil pesertaFasa 2
Umur 1 hingga 17 · Semua jantina · Dikemas kini 12 Mei 2026 · NCT05003986Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
- University of Michigan, Ann Arbor
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 29 Apr 2026 · NCT05650619Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
- University of Michigan, Ann Arbor
Mengambil pesertaKajian pemerhatian
Umur 2 ke atas · Semua jantina · Dikemas kini 22 Dis 2025 · NCT05505500Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.